v3.25.2
EARNINGS PER SHARE
 6 Months Ended
Jun. 28, 2025
Earnings Per Share [Abstract]  
EARNINGS PER SHARE EARNINGS PER SHARE
The following table reconciles net earnings (loss) and the weighted-average shares outstanding used to calculate basic and diluted earnings per share of common stock for the three and six months ended June 28, 2025 and June 29, 2024:
Second QuarterYear-to-Date
2025202420252024
Numerator (in millions):
Net earnings (loss) from continuing operations $101.9 $(19.2)$192.3 $0.3 
Net earnings from discontinued operations— 8.0 — 8.0 
Net Earnings (Loss)$101.9 $(11.2)$192.3 $8.3 

Second QuarterYear-to-Date
2025202420252024
Denominator (in thousands):
Basic weighted-average shares outstanding151,231 150,394 151,122 150,311 
Dilutive effect of stock contracts and awards497 — 589 701 
Diluted weighted-average shares outstanding151,728 150,394 151,711 151,012 

Second QuarterYear-to-Date
2025202420252024
Earnings (loss) per share of common stock:
Basic earnings (loss) per share of common stock:
Continuing operations$0.67 $(0.13)$1.27 $— 
Discontinued operations$— $0.05 $— $0.05 
Total basic earnings (loss) per share of common stock$0.67 $(0.07)$1.27 $0.06 
Diluted earnings (loss) per share of common stock:
Continuing operations$0.67 $(0.13)$1.27 $— 
Discontinued operations$— $0.05 $— $0.05 
Total diluted earnings (loss) per share of common stock$0.67 $(0.07)$1.27 $0.05 


The following weighted-average stock options were not included in the computation of weighted-average diluted shares outstanding because the effect would be anti-dilutive (in thousands):
Second QuarterYear-to-Date
2025202420252024
Number of stock options6,552 5,739 6,153 5,367 
In March 2015, the Company entered into a forward share purchase contract with a financial institution counterparty for 3,645,510 shares of common stock. The contract obligates the Company to pay $350.0 million, plus an additional amount related to the forward component of the contract. In June 2024, the Company amended the forward share purchase contract and updated the final settlement date to June 2026, or earlier at the Company's option. The reduction of common shares outstanding was recorded at the inception of the forward share purchase contract in March 2015 and factored into the calculation of weighted-average shares outstanding at that time.